Status:
UNKNOWN
Vascular and Metabolic Changes in Postmenopausal Diabetics
Lead Sponsor:
Assiut University
Conditions:
Diabete Type 2
Eligibility:
FEMALE
50-70 years
Brief Summary
The presence of type 2 diabetes mellitus (T2DM) also increases the relative risk of developing cardiovascular disease in women compared to men. Carotid intima media thickness (IMTc) was increased with...
Detailed Description
Introduction Complications of diabetes, such as cardiovascular disease, are associated with increased mortality among type 2 diabetes mellitus patients. The presence of type 2 diabetes mellitus (T2DM)...
Eligibility Criteria
Inclusion
- post-menopausal women
- aged 50-70 years
- amenorrhea for over 24 months.
- The diabetic participants will receive their treatment for T2DM (oral hypoglycemic agents or insulin).
Exclusion
- Patients receiving hormone replacement therapy.
- History of abnormal vaginal bleeding.
- Patients receiving vitamin B12, vitamin D and folic acid regularly.
- History of malignancy or neurological diseases as epilepsy, parkinsonism and Alzheimer disease.
- Antifolate medications as methotrexate are excluded from the study.
Key Trial Info
Start Date :
October 2 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
November 15 2018
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT03273738
Start Date
October 2 2018
End Date
November 15 2018
Last Update
June 27 2018
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.